Bard Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,150
Closed -$1.16M 221
2024
Q2
$1.16M Hold
2,150
0.12% 111
2024
Q1
$1.11M Hold
2,150
0.12% 112
2023
Q4
$1.01M Hold
2,150
0.11% 117
2023
Q3
$936K Hold
2,150
0.12% 113
2023
Q2
$955K Hold
2,150
0.07% 171
2023
Q1
$989K Hold
2,150
0.08% 173
2022
Q4
$1.1M Hold
2,150
0.09% 154
2022
Q3
$977K Hold
2,150
0.09% 156
2022
Q2
$1.04M Hold
2,150
0.09% 152
2022
Q1
$1.06M Hold
2,150
0.09% 154
2021
Q4
$997K Hold
2,150
0.08% 151
2021
Q3
$802K Hold
2,150
0.07% 157
2021
Q2
$821K Hold
2,150
0.07% 156
2021
Q1
$772K Hold
2,150
0.07% 154
2020
Q4
$690K Buy
+2,150
New +$660K 0.07% 158

Other funds holding ELV

Bard Financial Services's ELV Position: Q3 2024 in Review

Bard Financial Services sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2,150 shares — an estimated $1.16M sold.

Bard Financial Services first reported a position in ELV in Q4 2020 and held it in 15 quarters. The position peaked at $1.16M in Q2 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Bard Financial Services reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Bard Financial Services sold 2,150 Elevance Health shares in Q3 2024, an estimated $1.16M.
  • Bard Financial Services first reported a position in Elevance Health in Q4 2020 and held it in 15 quarters.
  • Bard Financial Services's Elevance Health position peaked at $1.16M in Q2 2024.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Bard Financial Services's 13F filing for Q3 2024, filed 4 Oct 2024.